Linagliptin

Anter

• Ma mua o ka lawe ʻana i ka linagliptin,
• Hiki i kēia lāʻau ke hoʻololi i kāu kō kō. Pono ʻoe e ʻike i nā ʻōuli o ke kō a me ke kō i kō a me nā mea e hana inā loaʻa kēia mau hōʻailona iā ʻoe.
• Hiki i ka Linagliptin ke kumu i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e hōʻoki i ka lawe ʻana i ka linagliptin a kāhea koke aku i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

Hoʻohana ʻia ʻo Linagliptin me ka papaʻai a me ka hoʻoikaika kino a i kekahi manawa me nā lāʻau ʻē aʻe e hoʻohaʻahaʻa i nā pae kō kō i nā mea maʻi me ka maʻi diabetes type 2 (ke ʻano kiʻekiʻe ke kō kō no ka mea ʻaʻole hana a hoʻohana ʻole ke kino i ka insulin maʻamau). Aia ʻo Linagliptin i loko o ka papa o nā lāʻau i kapa ʻia he mau mea kūpale dipeptidyl peptidase-4 (DPP-4). Hana ia ma ka hoʻonui ʻana i ka nui o kekahi mau mea kūlohelohe e hoʻohaʻahaʻa i ke kō kō ke kiʻekiʻe. ʻAʻole hoʻohana ʻia ʻo Linagliptin e mālama i ka maʻi diabetes 1 (kahi a ke kino e hana ʻole ai ka insulin a, no laila, ʻaʻole hiki ke kaohi i ka nui o ke kō i ke koko) a i ʻole ka ketoacidosis diabetic (kahi kūlana koʻikoʻi e ulu inā ʻaʻole mālama ʻia ke kō kiʻekiʻe. ). ʻO Linagliptin i hoʻohana ʻia me ka insulin e mālama i ka maʻi diabetes ʻaʻole i aʻo ʻia a hiki i kēia lā.

I ka hala ʻana o ka manawa, hiki i ka poʻe i loaʻa i ka maʻi diabetes a me ke kō kō ke kiʻekiʻe ke hoʻomohala i nā pilikia koʻikoʻi a i ʻole hoʻoweliweli i ke ola, e like me ka maʻi puʻuwai, ka hahau, nā pilikia o ka puʻupaʻa, nā ʻeha o ke aʻa, a me nā pilikia o ka maka. ʻO ka lawe ʻana i nā lāʻau (s), ka hoʻololi ʻana i ka nohona (e laʻa me ka papaʻai, hoʻoikaika kino, haʻalele i ka puhipaka), a me ka nānā pinepine ʻana i kāu kō kō e kōkua paha i ka mālama ʻana i kāu maʻi kō. Hoʻoemi paha kēia hoʻomaʻamaʻa i kou manawa e loaʻa ai ka puʻuwai puʻuwai, hahau ʻana, a i ʻole nā ​​pilikia e pili ana i ka maʻi diabetes e like me ka hōʻino ʻana o ka puʻuwai, nā ʻāʻī nerve (numb, nā wāwae anu a i ʻole nā ​​wāwae; hoʻemi i ka hiki i ka wahine i nā kāne a me nā wahine), nā pilikia o ka maka, me nā loli. a i ʻole ka nalo ʻana o ka ʻike, a i ʻole ka maʻi gum. E kamaʻilio pū kāu kauka a me nā mea lawelawe ʻē aʻe iā ʻoe e pili ana i ke ala maikaʻi loa e mālama ai i kāu maʻi diabetes.

Hele mai ʻo Linagliptin ma ke ʻano he papa e lawe ma ka waha. Lawe ʻia ia i hoʻokahi manawa i ka lā me ka ʻai ʻole. Lawe i ka linagliptin ma kahi o ka manawa like i kēlā me kēia lā. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. Lawe pololei i ka linagliptin e like me ke kuhikuhi. Mai lawe i ka mea ʻoi aku a liʻiliʻi paha o ia mea a lawe pinepine iā ia ma mua o ka mea i kauoha ʻia e kāu kauka.

Kōkua ʻo Linagliptin i ka mālama ʻana i ke kō kō kiʻekiʻe akā ʻaʻole hoʻōla i ka maʻi kō. E hoʻomau i ka lawe ʻana i ka linagliptin ʻoiai inā maikaʻi ʻoe. Mai hōʻoki i ka lawe ʻana i ka linagliptin me ka walaʻau ʻole ʻana me kāu kauka.

E hāʻawi aku kāu kauka a mea kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui o ka mea hana (Kauka Lapaʻau) ke hoʻomaka ʻoe i ka lāʻau me ka linagliptin a i kēlā me kēia manawa e hoʻopiha hou i kāu kuhikuhi. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka lawe ʻana i ka linagliptin,

• e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka linagliptin, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i nā papa linagliptin. E noi i kāu kauka lāʻau a nānā paha i ka ʻike hoʻomanawanui o ka mea hana no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau he aha nā lāʻau lapaʻau a me nā lāʻau ʻole i kuhikuhi ʻia, nā wikamina, a me nā mea hoʻopihaʻaiʻai āu e lawe nei a hoʻolālā paha e lawe. E haʻi pono i kekahi o kēia mau mea: carbamazepine (Tegretol); insulina; nā lāʻau lapaʻau no ka maʻi kō e like me acetohexamide, chlorpropamide (Diabinese), glimepiride (Amaryl, ma Avandaryl), glipizide (Glucotrol, ma Metaglip), glyburide (Diabeta, Glynase, Micronase, i Glucovance), nateglinide (Starlix), pioglitazone (Actoside) ma Actoplus Met, ma Duetact), repaglinide (Prandin), rosiglitazone (Avandia, ma Avandamet, ma Avandaryl), tolazamide, a me tolbutamide; phenytoin (Dilantin); phenobarbital; rifabutin (Mycobutin); rifampin (Rifadin, ma Rifamate, ma Rifater); and ritonavir (Norvir, in Kaletra). Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka a me ka mea kauka lāʻau he aha nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe, ʻo ka wort ʻo St.
• e haʻi i kāu kauka inā ua loaʻa a loaʻa paha iā ʻoe ka pancreatitis (hoʻāhu ʻana o kāu pancreas), nā pōhaku (nā pōhaku i loko o kāu gallbladder), a i ʻole triglycerides kiʻekiʻe (kahi mea momona i ke koko), a inā ʻoe e inu a inu paha i ka nui o ka waiʻona .
• E haʻi i kāu kauka inā hāpai ʻoe, e hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka lawe ʻana i ka linagliptin, e kāhea i kāu kauka.
• inā ke ʻoki nei ʻoe, e like me ke ʻoki niho, e haʻi i ke kauka a i ʻole kauka niho paha e lawe ana ʻoe i ka linagliptin.
• e kamaʻilio me kāu kauka e pili ana i ka mea āu e hana ai inā ʻeha ʻoe a i ʻole inā e loaʻa ʻoe i kahi kuni a maʻi paha. Hiki i kēia mau kūlana ke hoʻololi i kāu kō kō a me ka nui o ka linagliptin āu e pono ai no ka mālama ʻana.

E mālama pono i nā ʻōlelo aʻoaʻo a pau a me nā hoʻoikaika kino i hana ʻia e kāu kauka a i ʻole kauka. He mea nui ka ʻai ʻana i ka papaʻai olakino, hoʻoikaika kino mau, a lilo i ka paona inā pono. E kōkua kēia i ka mālama ʻana i kāu maʻi diabetes a kōkua i ka linagliptin e hana me ka maikaʻi.

E lawe i ka lāʻau i hala i kou wā e hoʻomanaʻo ai. Eia nō naʻe, inā kokoke i ka manawa no ka mahele hope aʻe, e lele i ka lāʻau i hala a hoʻomau i kāu papa hana maʻamau. Mai lawe i kahi lāʻau pālua e pani no kahi mea i hala.

Hiki i kēia lāʻau ke hoʻololi i kāu kō kō. Pono ʻoe e ʻike i nā ʻōuli o ke kō a me ke kō i kō a me nā mea e hana inā loaʻa kēia mau hōʻailona iā ʻoe.

Hiki i ka Linagliptin ke kumu i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ʻeha poʻo
• ʻeha pū

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e hōʻoki i ka lawe ʻana i ka linagliptin a kāhea koke aku i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• hūwī
• ʻili, ʻili ʻana, a me ka ʻili ʻana o ka ʻili
• hives
• pehu o ka maka, lehelehe, alelo, a puʻu paha
• pilikia i ka hanu ʻana a i ʻole ke ale ʻana
• hulahula
• ʻeha mau e hoʻomaka i ka hema hema a i ʻole ka waena o ka ʻōpū akā hiki ke pālahalaha i ka hope
• nausea
• ka luaʻi
• nalo ʻai ʻole

Hiki i ka Linagliptin ke kumu i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama iā ia i ka mahana wela o ka lumi a ma kahi o ka wela a me ka momona (ʻaʻole i ka lua.

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. ʻO kāu kō kō a me ka hemoglobin glycosylated (HbA1c) e nānā mau ʻia e hoʻoholo ai i kāu pane i ka linagliptin. E haʻi aku kāu kauka iā ʻoe pehea e nānā ai i kāu pane i ka linagliptin ma ke ana ʻana i kāu mau kō kō i ka home. E hāhai pono i kēia mau ʻōkuhi.

Pono ʻoe e ʻaʻa mau i ke kūpeʻe kuhi diabetic e ʻike pono i ka loaʻa ʻana o kahi lāʻau kūpono i kahi ulia pōpilikia.

Mai ʻae i kahi mea ʻē aʻe e lawe i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Tradjenta^®
• Trijardy^® (ma ke ʻano he huahana i hui ʻia me Empagliflozin, Linagliptin, Metformin)

• ʻO Glyxambi^® (nona ka Linagliptin, Empagliflozin)
• ʻO Jentadueto^® (loaʻa iā Linagliptin, Metformin)